Real-world study compares discontinuation rates of tofacitinib and TNFi in RAMarch 27, 2023Rheumatoid Arthritis
Systemic immune-inflammation index: Novel biomarker to predict RA risk in adultsMarch 27, 2023Rheumatoid Arthritis
Joint damage associated with increased disability but not pain in early RAMarch 27, 2023Rheumatoid Arthritis
Pretreatment calprotectin offers no additional variability beyond CRP in predicting response to TNFi in RAMarch 27, 2023Rheumatoid Arthritis
Real-world study: Predictors of long-term remission in rheumatoid arthritisMarch 27, 2023Rheumatoid Arthritis
Early menopause worsens disease outcomes in postmenopausal women with RAMarch 27, 2023Rheumatoid Arthritis
CT-based screening for malignancies may benefit patients with RA who initiated b/tsDMARDMarch 27, 2023Rheumatoid Arthritis
RA raises risk for long-term MACE in patients undergoing percutaneous coronary interventionMarch 27, 2023Rheumatoid Arthritis
Higher disability at early stages raises risk for progression to difficult-to-treat RAMarch 27, 2023Rheumatoid Arthritis
Administering concomitant methotrexate at a half vs usual dose while initiating TNFi is feasibleMarch 27, 2023Rheumatoid Arthritis
Rheumatology NewsAnifrolumab shows promise in refractory discoid lupus erythematosusMarch 27, 2023Lupus & Connective Tissue Diseases
Rheumatology NewsNew data forecast more oral PDE4 inhibitors for psoriasisMarch 27, 2023Psoriatic Arthritis
Rheumatology NewsCT results in myositis inform cancer screening strategiesMarch 24, 2023Lupus & Connective Tissue Diseases
Rheumatology NewsTofacitinib may have possible protective effect against ILD in RAMarch 24, 2023Rheumatoid Arthritis
